Identification of potent new brain cancer EGFR inhibitor from usimine A and usimine B: computer-aided drug design perspective
Brain cancer ranks 10th among cancer-related causes of death for patients worldwide. Medical chemists still have many challenges because of the high side effects, increasing tumor resistance, and low selectivity of new chemotherapeutic medications despite the enormous effort put out to extract, deve...
Saved in:
Main Authors: | Roney, Miah, Issahaku, Abdul Rashid, Wilhelm, Anke, Mohd Fadhlizil Fasihi, Mohd Aluwi |
---|---|
Format: | Article |
Language: | English |
Published: |
AMG Transcend Association
2024
|
Subjects: | |
Online Access: | http://umpir.ump.edu.my/id/eprint/43150/1/Identification%20of%20Potent%20New%20Brain%20Cancer%20EGFR%20Inhibitor%20from%20Usimine%20A%20and%20Usimine%20B%20-%20Computer-Aided%20Drug%20Design%20Perspective.pdf http://umpir.ump.edu.my/id/eprint/43150/ https://nanobioletters.com/wp-content/uploads/2024/09/LIANBS134.153.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computational screening of FDA-approved hepatitis c drugs for inhibition of VEGFR2 in liver cancer
by: Roney, Miah, et al.
Published: (2024) -
Computer-aided anti-cancer drug discovery of EGFR protein based on virtual screening of drug bank, ADMET, docking, DFT and molecular dynamic simulation studies
by: Roney, Miah, et al.
Published: (2023) -
Cancer drug resistance is a serious threat in Bangladesh
by: Roney, Miah, et al.
Published: (2024) -
The importance of in-silico studies in drug discovery
by: Roney, Miah, et al.
Published: (2024) -
Mefenamic acid inhibit transforming growth factor-beta type-1: Repurposing anti-inflammatory drugs in wound healing using in-silico approaches
by: Roney, Miah, et al.
Published: (2023)